AMLOGENYX

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Sept 2024 filing date already counts against anyone who files later.

Record

Serial number

98745183

Mark type

Word mark

Filed

11 Sept 2024

Published for opposition

06 May 2025

Attorney of record

John Paul Oleksiuk

Goods and services

• Class 001 — Chemicals: Chemical, biological, and biochemical preparations for use in gene delivery technology, namely, nucleic acids in the nature of coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and regulatory sequences, for scientific purposes for use in vitro laboratory use; chemical, biological, and biochemical preparations for use in the manufacture of pharmaceutical preparations
• Class 005 — Pharmaceuticals: Chemical, biological, and biochemical preparations for use in gene delivery technology, namely, nucleic acids in the nature of coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and regulatory sequences, for medical purposes for use in vitro laboratory use

Owner

• Amlogenyx Inc., Novato, CA, US
• Amlogenyx Inc., Novato, CA, US

Prosecution history

• 06 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 05 Jun 2026 — SOU EXTENSION 2 GRANTED
• 05 Jun 2026 — SOU EXTENSION 2 FILED
• 05 Jun 2026 — SOU TEAS EXTENSION RECEIVED
• 04 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 03 Oct 2025 — SOU EXTENSION 1 GRANTED
• 03 Oct 2025 — SOU EXTENSION 1 FILED
• 03 Oct 2025 — SOU TEAS EXTENSION RECEIVED
• 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 06 May 2025 — PUBLISHED FOR OPPOSITION
• 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 03 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 28 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 28 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE